Breast cancer 'wonder drug' increases risk of rare tumour by 440% (Daily Mail, 26 August 2009)

26 Aug 2009


A side effect of Tamoxifen, used effectively to treat oestrogen-sensitive breast tumours has been revealed. A study shows the drug increases the risk of a rarer oestrogen-insensitive tumour developing in the opposite breast.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story


Top stories

Website Refresh!
20 Dec 2024

Most read